A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis.
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis. NPJ Breast Cancer. 2018; 4:9.